翻訳と辞書 |
Eglumegad
Eglumegad (LY354740) is a research drug developed by Eli Lilly and Company, which is being investigated for its potential in the treatment of anxiety and drug addiction. It is a glutamate derived compound and its mode of action implies a novel mechanism. ==Mechanism of action== Eglumegad acts as a group-selective agonist for the group II metabotropic glutamate receptors (mGluR2/3). It is unclear whether eglumegad directly interacts with dopamine D2 receptors.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Eglumegad」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|